Evaluation of Clinical and Cost-effectiveness of Different Mouthwashes on Controlling Halitosis Among a Group of Egyptian Children
Launched by CAIRO UNIVERSITY · May 24, 2021
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
For both interventions:
1. Eligibility screen and patient selection according to the inclusion and exclusion criteria.
2. Readings for halitosis will be recorded using Tanita HC-312F Fitscan Portable Breath Checker (Tanita Corporation, Japan) that shows red, yellow and green colors indicating halitosis degree.
* Green color=no odour
* Yellow color=moderate odour
* Red color=intense odour Children with yellow or red colored results will be included.
3. Participants will be provided with information regarding the risks and benefit of the study and written informed consent will be o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 8-12 years old.
- • Cooperative children.
- • Both genders.
- • Medically free to exclude systemic cause of halitosis.
- • Bad breath
- Exclusion Criteria:
- • Children using any other oral hygiene aid other than routine teeth brushing.
- • Children with a known history of allergy to any mouthwash or drug.
- • Parents refuse to participate in the trial.
- • Treatment by antibiotic within one month before the trial(Pham \& Nguyen, 2018).
- • Abscess, draining sinus, cellulitis, or other conditions requiring emergency dental treatment.
- • Children using fixed or removable orthodontic appliances or dentures.
- • Children with a history of deleterious oral habits of mouth breathing.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials